<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0001397'>Fatty liver</z:hpo> and hepatic <z:chebi fb="0" ids="17855">triglyceride</z:chebi> accumulation are strongly associated with <z:hpo ids='HP_0001513'>obesity</z:hpo>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and are subject to nutritional influences </plain></SENT>
<SENT sid="1" pm="."><plain>Hepatic regulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> homeostasis is influenced by a complex system of hormones, hormonally regulated signalling pathways and transcription factors </plain></SENT>
<SENT sid="2" pm="."><plain>Recently, considerable progress has been made in elucidating molecular pathways and potential factors that are affected in insulin-resistant states </plain></SENT>
<SENT sid="3" pm="."><plain>In this review we discuss some of the key factors that are involved in both the regulation of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism in the liver </plain></SENT>
<SENT sid="4" pm="."><plain>Understanding the molecular network that links hepatic <z:chebi fb="23" ids="18059">lipid</z:chebi> accumulation and impaired <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism may provide targets for dietary or pharmacological interventions </plain></SENT>
</text></document>